Celadon Pharmaceuticals Plc (LON:CEL – Get Free Report)’s stock price shot up 15.2% during trading on Wednesday . The stock traded as high as GBX 19 ($0.24) and last traded at GBX 19 ($0.24). 432,700 shares changed hands during trading, an increase of 48% from the average session volume of 292,733 shares. The stock had previously closed at GBX 16.50 ($0.21).
Celadon Pharmaceuticals Stock Performance
The stock has a market cap of £11.65 million, a PE ratio of -2.38 and a beta of -0.26. The stock has a fifty day simple moving average of GBX 18.45 and a two-hundred day simple moving average of GBX 25.96. The company has a debt-to-equity ratio of 196.67, a quick ratio of 6.97 and a current ratio of 1.92.
About Celadon Pharmaceuticals
Celadon Pharmaceuticals Plc is a UK-based pharmaceutical company focused on the development, production and sale of breakthrough cannabis-based medicines. Its primary focus is on improving quality of life for chronic pain sufferers, as well as exploring the potential of cannabis-based medicines for other conditions such as autism.
Featured Articles
- Five stocks we like better than Celadon Pharmaceuticals
- What is the Nasdaq? Complete Overview with History
- Solid Biosciences Soars 32% on Trial Data: 189% Upside from Here?
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Up Nearly 1000%, Can AppLovin Keep Delivering for Investors?
- Why Invest in High-Yield Dividend Stocks?
- Alphabet’s Pullback Just Opened a Window for Smart Investors
Receive News & Ratings for Celadon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celadon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
